ArticlePharmaceutical research2018

Activity of Indatuximab Ravtansine against Triple-Negative Breast Cancer in Preclinical Tumor Models.

Kurt Schönfeld et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.